SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Dolan Dan

(Last) (First) (Middle)
C/O RADIUS HEALTH, INC.
950 WINTER STREET

(Street)
WALTHAM MA 02451

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
09/24/2020
3. Issuer Name and Ticker or Trading Symbol
Radius Health, Inc. [ RDUS ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
See Remarks
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) (1) 08/15/2027 Common Stock 12,000 34.89 D
Stock Option (Right to Buy) (2) 02/13/2028 Common Stock 16,000 37.75 D
Stock Option (Right to Buy) (3) 02/22/2029 Common Stock 10,000 19.18 D
Stock Option (Right to Buy) (4) 03/02/2030 Common Stock 10,000 20.25 D
Restricted Stock Units(5) (6) (7) Common Stock 4,125 0.00 D
Restricted Stock Units(5) (8) (7) Common Stock 14,667 0.00 D
Restricted Stock Units(5) (9) (7) Common Stock 5,500 0.00 D
Explanation of Responses:
1. 25% of this option vested on 8/15/2018; and the remaining shares shall vest in equal monthly installments over 36 months.
2. 25% of this option vested on 2/13/2019; and the remaining shares shall vest in equal monthly installments over 36 months.
3. 25% of this option vested on 2/22/2020; and the remaining shares shall vest in equal monthly installments over 36 months
4. 25% of this option shall vest on 3/2/2021; and the remaining shares shall vest in equal monthly installments over 36 months
5. Each Restricted Stock Unit represents a contingent right to receive one share of common stock.
6. 25% of this Restricted Stock Unit grant vested on 2/22/2020, with the remaining 75% of the grant vesting annually over a period of 3 years.
7. Not applicable.
8. 33.33% of this Restricted Stock Unit grant vested on 6/6/2020, with the remaining 66.66% vesting on 6/6/2022.
9. This Restricted Stock Unit grant shall vest 33.33% annually over a period of 3 years.
Remarks:
/s/ Dan Dolan 10/06/2020
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.